Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Toray Industries prepares and tests agents for urinary incontinence

Oct. 6, 2016

FDA grants orphan drug designation to AbbVie's atrasentan

Oct. 5, 2016

Dimerix reports positive safety data for phase II trial of DMX-200

Oct. 5, 2016

twoXAR collaborates with Mount Sinai researchers in diabetic nephropathy

Oct. 5, 2016

Peloton Therapeutics describes HIF-2alpha inhibitors

Sep. 26, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent agents for nocturia

Sep. 23, 2016

Regulus begins phase II trial of RG-012 in Alport syndrome

Sep. 22, 2016

Bayer and Evotec establish 5-year research partnership in kidney disease

Sep. 22, 2016

Promising phase II topline results for sparsentan in focal segmental glomerulosclerosis

Sep. 8, 2016

Aquinox initiates phase III study of AQX-1125 for interstitial cystitis/bladder pain syndrome

Sep. 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...